Seeking Alpha

deeppocketsgolf

deeppocketsgolf
Send Message
View as an RSS Feed
View deeppocketsgolf's Comments BY TICKER:
Latest  |  Highest rated
  • ERF Wireless (ERFW) Improves Balance Sheet and Operations in Preparation of Further Expansion [View instapost]
    Update on ERFW:ERF Wireless

    messages.finance.yahoo...

    See Yahoo Finance Message Post.
    Jul 13, 2011. 10:03 AM | Likes Like |Link to Comment
  • Reach Messaging Holdings, Inc. (RCMH.OB) Goes Public on OTCBB [View instapost]
    RCMH.OB:Reach Messaging Holdings Inc.

    Reach Messaging Holdings Inc. helps companies extend their brands through customized mobile applications and Bots used on instant messaging (IM) platforms. Since 2007, Reach Messaging has been in the Bot development business for America Online (seekingalpha.com/symbo...), which operates on the AOL Instant Messenger (seekingalpha.com/symbo...). The Company is transitioning to the mobile applications market and is currently developing a variety of apps for social media platforms including Facebook and all of the major mobile devices such as the iPhone, BlackBerry, Android and Digital Signage.

    For more information, please visit www.reachmessaging.com

    A leading developer of industry specific mobile phone application and specialized platform technology, today announced the Company will be launching a Physical Fitness App through which "CrossFit" athletes can communicate, challenge and compete with one another. The app will be available on the iPhone and Droid upon release, which the Company anticipates in the near future.

    The mobile app itself will be a comprehensive tool designed specifically for the CrossFit athlete and include all the necessary tools for CrossFit such as a timer, list of CrossFit specific exercises to reference, Workout of the Day (seekingalpha.com/symbo...) tracker, and the ability to locate the nearest CrossFit Affiliate Gym. Additionally, the app will have a unique feature that allows CrossFit athletes all over the world to challenge other users, friends or random opponents to a specific workout. The user being challenged will be notified through push notification.

    Reach Messaging Signs Deal With Mall Development Company to Use Its "Mall Buddy 2.0" Mobile App Throughout 12 Retail Mall Locations
    Company's First Multi-Mall Deal is With the Largest Privately Owned Shopping Center Development and Management Company in the US.

    Reach Messaging's "Mall Buddy 2.0" Platform is a free mobile app that consumers can download and use when shopping at participating retail malls. The app includes features such as "Reward Zone" gift card integration as well as other coupons and specials offered by stores in and around the mall, friend finder to locate other users in the area, one touch access to mall security and directions the mall. As outlined in the agreement, Reach Messaging will get a percentage of revenue generated by advertising sales to retail stores in and around the malls.

    Per Equity @ .00478 / Share; Current Market Cap 4M; [Paid In Equity 4.835M], 840M Shares O/S.

    Sum Trading At: ,Primary Metric per Equity: ($0.244208) M, 406.3 ,Metric Weighted per Price Range / Change, 6.301_404 ,Combined Weight Adj Trade Metric, 593.740 ,for -($1.044)M Market Cap, for, (0.001244) off adjusted level price of .006024;

    Estimate of Forward Activity:

    Equity $$MM: (0.244208)
    MinRetGrowth: 0.03
    MinRetInv: 0.05
    Weighted Cost of Capital: 78.5%
    Estimated Local Continuing Value in $$M: (0.132502)
    Estimated Factor NOT LOCAL in $$M: 9.412007
    Estimated ContinuingValue :In Line With Avg Oper Loss Annualized MRQ $M: '10 & '11: (1.247,113)
    Est NOT LOCAL Price / 1.07M Market Cap : 0.001274_24_22
    (0.0015), ,Factor Forward.
    (0.858), ,Not Local Price To.

    Quote: Enter RCMH and Get Info @

    otcbb.com/asp/Info_Cen...

    Profile:

    www.reachmessaging.com

    2010:85 Cents;

    Volume YTD:66.119M Shares;

    Do not own Shares; New Today; It appears to be an interesting speculative tech company; Review Company;

    Noted:

    1.0 HUF = 0.005_0222_38_43_09_9 AUD
    1 AUD = 198.75 HUF

    Jul 11, 2011. 11:22 AM | Likes Like |Link to Comment
  • Mobile apps for paying the tab, browsing beers [View article]
    The article above is interesting; Mobile Apps can certainly be a part of restaurant systems integration; Should be easy to integrate;

    XFMY is a Restaurant Reporting Company;

    XFormity provides technology and services to multi-unit business operators. The Company’s core products are hosted Business Intelligence (BI), Balanced Scorecard and Benchmarking solutions. These solutions help customers with operational data analysis, trend reporting, issue identification and tracking. The Company provides data integration and management services which feed the BI and Scorecard solution with data from many key data sources. The Company’s solutions are provided to customers as a hosted (software-as-a-service) model, which allows the Company to rapidly configure and implement solutions for new customers in an affordable, cost-effective manner.

    The Company provides services for franchisors and franchisees in a growing list of customers across the United States and Canada. XFormity is the provider of Burger King Corporation's (seekingalpha.com/symbo...) operational reporting for all company owned and operated restaurants in the US and Canada. In addition to this deployment, the Company's success in delivering solutions on a big scale is demonstrated by the use of its balanced scorecard and financial benchmarking tools for all Burger King Corporate restaurants in the United States and Canada, totalling nearly 6,500 restaurants.

    Per Recent Quarter Report; Profit and Loss, 3 & 9 Mos Combined;

    @ 3.75 Cents;

    Report Category, ,Notes, Per Report, Price: , Metric. , Weight. , Combined Trading Metric ,Year / Designation / DAY(seekingalpha.com/symbol/s) Weight Adj Price.
    20.Sales: 1.786 ,$M Report 10-Q :, 0.037500 , 1.09 , 0.80 , 0.87 ,July 2011, 0.03

    21. COS: (1.343) ,$M Report 10-Q :, 0.037500 , (1.45) , 0.93 , (1.35) ,July 2011, 0.04

    22. Interest Expense: (0.157) ,$M Report 10-Q :, 0.037500 , (12.41) , 1.09 , (13.56) ,July 2011, 0.04

    23. Tax or Other: 0.574 ,$M Report 10-Q :, 0.037500 , 3.39 , 1.08 , 3.66 ,July 2011, 0.04

    24. Research & Development: (0.507) ,$M Report 10-Q :, 0.037500 , (3.84) , 0.80 , (3.07) ,July 2011, 0.03

    Profit or Loss for MRQ$M: $0.353; Sum Trading At: ,Primary Metric(s) per Statement: (13.219) ,Metric Weighted per Price Range / Change, 4.704_404 ,Combined; Weight Adj Trade Metric, (13.461), for +0.115M Market Cap; for +0.0022 on level price of 3.53 Cents;

    Estimate of Forward Activity:

    Profit / Loss MRQ $$M: 0.353
    MinRetGrowth: 0.03
    MinRetInv: 0.05
    Weighted Cost of Capital: 77.636%
    Estimated Local Continuing Value in $$M: 0.1603
    Estimated Factor NOT LOCAL in $$M: 12.699047
    Estimated ContinuingValue: Forward Sales / In Line With 3 & 9 Mos Combined $$M: 2.04
    Estimated NOT LOCAL Price / 2.375M Market Cap: 0.04_5_75
    0.04, Factor Forward,
    1.16_7 Not Local Price To,

    Recent Share Equity Reported As (1.901,666M), With Paid In Equity of 7M;

    It is odd that there has been no news since 7-24-09;
    Last Reported News:
    XFormity Releases a New and Innovative Cash Management Solution for Restaurant Operators

    The release of a powerful new solution which helps restaurant operators identify and manage issues surrounding cash management. In response to many customers' cries for help for XFormity has developed an intuitive solution for analyzing thousands of transactions quickly, identifying transactions, and the responsible cashiers that are outside acceptable ranges.

    Building on the wealth of experience and success in providing time-savings solutions to restaurant operators across America, Canada, and Latin America;

    2002:3.00+, Do not Own Shares; Review Company;
    Jul 11, 2011. 08:11 AM | Likes Like |Link to Comment
  • Dialogic and Iperia Collaborate to Provide Innovative Video Mail Solution for deltathree [View article]
    DDDC, DeltaThree mentioned Above;

    Dialogic and Iperia Collaborate to Provide Innovative Video Mail Solution for deltathree.....

    Company Statement:
    [deltathree's revenue declined sequentially primarily due to a slowdown in reseller revenues concentrated in the Middle East region during the first quarter of 2011.]


    Advanced VOIP Telephony Services:
    Founded in 1996, deltathree, Inc. is a global provider of video and voice over Internet Protocol (VoIP) telephony services, products, hosted solutions and infrastructures for service providers, resellers and direct consumers.
    Supporting tens of thousands of active users around the world, deltathree serves customers through its service provider and reseller channel and its direct-to-consumer channel. deltathree's advanced solutions offer service providers and resellers a full spectrum of private label IP-based digital voice and video products and services, as well as a back-office suite of services.
    Utilizing an advanced Session Initiation Protocol (SIP) technology platform, deltathree [D3_C] provides all the components to support a complete VoIP service deployment. deltathree's direct-to-consumer channel consists of the joip Mobile, joip and iConnectHere direct-to-consumer offerings.

    @ 7.72 Cents, Per Profit / Loss MRQ: Previous Close @ 9 Cents;

    Report Category, ,Notes, Per Report, Price: , Metric. , Weight. , Combined Trading Metric ,Year / Designation / DAY(S) Weight Adj Price.

    20.Sales: 3.784 ,$M Report 10-Q :, 0.077200 , 1.475 , 1.17 , 1.72 ,July 2011, 0.09

    21. COS: (3.13) ,$M Report 10-Q :, 0.077200 , (2) , 1.17 , (2.08) ,July 2011, 0.09

    22. Interest Expense: (0.19) ,$M Report 10-Q :, 0.077200 , (30) , 1.00 , (30.16) ,July 2011, 0.077

    23. Tax or Other: (0.006) ,$M Report 10-Q :, 0.077200 , (930) , 1.00 , (930) ,July 2011, 0.077

    24. Research & Development: (0.433) ,$M Report 10-Q :, 0.077200 , (12.9) , 1.00 , (12.84) ,July 2011, 0.077

    Profit or Loss for MRQ $M: $0.03, Sum Trading At: ,Primary Metric(s) per Statement: (973.315) ,Metric Weighted per Price Range / Change, 5.32_7_72_404 ,Combined; Weight Adj Trade Metric, (973.321), for (0.365708) Market Cap, for (0.005) off .082;

    Estimate of Forward Activity:

    Profit / Loss MRQ $$M: 0.03
    MinRetGrowth: 0.03
    MinRetInv: 0.05
    Weighted Cost of Capital: 98.907%
    Estimated Local Continuing Value in $$M: 0.010
    Estimated Factor NOT LOCAL in $$M: 1,530.000712
    Estimated ContinuingValue: Forward Annualized Sales $$MM: 15.136,057
    Estimated NOT LOCAL Price / 17.507M Market Cap / Buyout Minimum Amount: 24.22_27_7 Cents per Share;
    0.21, Factor Forward,
    1.15_66_19, or 1.16 Not Local Min Buyout Price To,

    Most Recent Annual Filing:Share Equity (3.560M), with Paid In Equity of 175M;

    2005:$6.20 / Share on 3M Shares Trading on Nasdaq as DDDC;
    [Filed SEC Form 25-NSE; Removal from National Exchange, Circa 2007]

    Volume YTD: 1.815_119.66M Shares;

    Quote:Enter DDDC and Get Info @

    otcbb.com/asp/Info_Cen...

    Profile:

    finance.yahoo.com/q/pr...

    Do Not presently own Shares of DDDC; Have Owned Shares of DDDC; Review the Company;
    Jul 10, 2011. 10:22 AM | Likes Like |Link to Comment
  • NewCardio (NWCI) Chosen to Provide QTinno Technology by Major Pharmaceutical Company [View instapost]
    NWCI, NewCardio: Recently presented @ The Wells Fargo Securities Healthcare Conference;

    Which gave it a 8 Cent boost; from 25 Cents;[2.599M Market Cap]

    Per Equity @ 32 Cents; Recent Quarterly Report;

    Report Category, ,Notes, Report, Price, , Metric, , Weight, , Primary Weight Adj Trading Metric, ,Year / Desig/ DAY Weight Adj Price.

    20. Deficit, (45) ,M, 10-Q 0.32 , (0.23) , 0.9063 , (0.21) ,July 2011, 0.29

    21. Paid In Equity, 40 ,M, 10-Q 0.32 , 0.26 , 0.7813 , 0.20 ,July 2011, 0.25

    22. Preferred, 0.000015 ,M, 10-Q 0.32 , 693019 , 1.015 , 703,629 ,July 2011, 0.32

    23. Common Stk Amt, 0.0308 ,M, 10-Q 0.32 , 337 , 1.000 , 337 ,July 2011, 0.32

    24. Other Inc or Loss 0.00 ,M, 10-Q 0.32 , 0.00 , 1.0313 , 0 ,July 2011, 0.33

    Sum Trading At: ,Primary Metric per Equity: ($4.428) M, 693,356 ,Metric Weighted per Price Range / Change, 4.73_404 ,Combined Weight Adj Trade Metric, 703,966.1_15_8_86_404 ,for +$0.553M Market Cap, for, 0.017 on adjusted level price of .303;

    Estimate of Forward Activity:

    Equity $$MM: (4.428)
    MinRetGrowth: 0.03
    MinRetInv: 0.05
    Weighted Cost of Capital: 92.47%
    Estimated Local Continuing Value in $$M: (1.992072)
    Estimated Factor NOT LOCAL in $$M: 4.824,522M
    Estimated ContinuingValue :In Line With R&D Expense Annualized MRQ / Net Loss ttm$$M: (9.610,792)
    Est NOT LOCAL Price / 5.24M Market Cap : 0.16_12_22
    (0.2959) ,Factor Forward.
    (0.54494) ,Not Local Price To.

    Current Market Cap 10.72M; Off the high of $1.15_66_19

    News / Recent Presentation's.
    NewCardio Selected to Present at Wells Fargo Securities Healthcare Conference.

    NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

    NewCardio Selected to present @ the Cardiac Diagnostic Technology at MDB Capital's Bright Lights Conference in New York City.

    NewCardio Selected to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development.

    About NewCardio, Inc.

    NewCardio is a cardiac diagnostic and services company developing and marketing proprietary software platform technologies to provide higher accuracy to, and increase the value of, the standard 12-Lead 3D ECG.
    NewCardio's 3D ECG technology software platform reduces the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect.
    NewCardio's software products and services significantly improve the diagnosis and monitoring of cardiovascular disease, as well as cardiac safety assessment of drugs under development.
    For more information, visit newcardio.com.

    Quote:Enter NWCI and Get Info @:

    otcbb.com/asp/Info_Cen...

    2008:4.32 / Share;

    Do not own Shares of NWCI, Review the Company; Looking for 16.22 Cents with Volume; Volume YTD: 5M Shares;
    Jul 8, 2011. 08:03 AM | Likes Like |Link to Comment
  • Suspect Detection Systems Inc. (SDSS.OB) is “One to Watch” [View instapost]
    SDSS: Suspect Detection Systems Inc.

    Co. Statement:
    - Total revenues during the past two years have exceeded $4M; During the quarter, the company completed a major sale to a governmental agency, and it is believed that follow-up sales with the customer are likely in the future.
    In addition, the company has begun raising capital, which is intended to enable the company to grow significantly as it builds toward the fulfillment of its full business plan. The capital raise is expected to be completed in the coming months.

    Per Equity @ 8.75 Cents; [Off the high of 11.2 Cents;],
    Gross Profit as % of Revenue MRQ 90%;
    Current Market Cap 6.507M;
    2009:27 Cents;

    Sum Trading At: ,Primary Metric per Equity: $1.357 M, 892 ,Metric Weighted per Price Range / Change, 4.63_4_38 ,Combined Weight Adj Trade Metric, 767.007 ,for +$0.5M Market Cap, for, 0.006398 on .081102 / Share;

    Estimate of Forward Activity:

    Equity $$MM: 1.357
    MinRetGrowth: 0.03
    MinRetInv: 0.05
    Weighted Cost of Capital: 139.622%
    Estimated Local Continuing Value in $$M: 0.399722M
    Estimated Factor NOT LOCAL in $$M: 16.212047M
    Estimated ContinuingValue :In Line With Sales Annualized 2011, MRQ: 6.480339M
    Est NOT LOCAL Price / 4.43M Market Cap : 0.0578
    0.085 ,Factor Forward.
    0.68_3 ,Not Local Price To.

    Quote:Enter SDSS and Get Info @

    otcbb.com/asp/Info_Cen...

    Profile:

    finance.yahoo.com/q/pr...

    Suspect Detection Systems Inc., through its subsidiary Suspect Detection Systems Ltd., is a developer of proprietary counter terrorism and crime prevention technology designed to identify threats in real-time, and prevent incidents before they are carried out.
    The technology platform detects the hidden "hostile intent" of assailants - before they commit their intended acts - with a high degree of accuracy.
    The system can also be used after a crime is committed to quickly identify criminals from among a general population pool, including suspects.

    Learn more about Suspect Detection Systems and Cogito Technology at

    www.sdss-corp.com.

    Volume YTD: 5M Shares;

    Do not own Shares of SDSS; Review Company; New Today;
    Jul 7, 2011. 08:38 AM | Likes Like |Link to Comment
  • LocatePC now Available With the World's 2nd Largest Retail Distributor of Software [View article]
    LGTT:LiGatt Security International: Pure High Tech Volume Play;

    Not intended to overwrite existing volume that has been quantified; Adding to the existing volume;

    Off the high of 40 Cents; Current Market Cap .768M;

    We have Volume; Effective in many ways, for many!!!

    @ 0.00019 / Share; Price Weighted Over 20.16 DAYS; Avg Volume per DAY (59.841M); @ Weighted Avg Price of 0.000174122; Market Cap for Sample 208,374K; [Volume has not gone below 104K]

    Per Volume Last 20.16_22_12 DAY(S), M of Shares: (1196.712) @ 0.00016, (0.2)M Market Cap; Sum Trading At: ,Primary Metric(s) per Volume; (0.212757) ,Metric Weighted per Price Range / Change, 4.22_10_404_6_8 ,Combined; Weight Adj Trade Metric, (0.17_10), for +0.227M Market Cap; for +0.00003 on level 0.00016;

    Estimate of Forward Activity Daily:[Would not be an exaggeration]

    Per Volume Last 20.16_22_12 DAY(seekingalpha.com/symbol/s), M of Shares: (1196.712)
    Min Volume Increase1: 0.2295
    Min Volume Increase2: 0.2294
    Min Volume Increase 3: 0.2212
    Estimated Minimum Volume Shares to Trade LocallyM: (63.304)
    Estimated Factor NOT LOCAL in $$M: 1.769_312
    Estimated Maximum Volume Shares to Trade LocallyM: (111.204)
    Estimated Potential LOCAL Price / Mkt Cap Price @ 1.536,072M: 0.000199999;
    (1.44_8_12%) Estimate of FWD Shares Traded per O/S Shares;
    0.8 Weighted Avg Price to Not Local Price;

    YTD:(50%), 3 Year, (98.3%)

    Apple Approves New App and Increases Demand for LocatePC in Retail Stores;

    www.dailyfinance.com/r...

    Website and Profile for LGTT;

    finance.yahoo.com/q/pr...

    Website: www.ligattsecurity.net

    www.ligattsecurity.com...

    Quote:
    www.dailyfinance.com/q...

    Trading Range appears to be .0001 to .0002; [ + or - ]

    Do not own Shares of LGTT; Review Company;





    Jul 6, 2011. 11:10 AM | Likes Like |Link to Comment
  • BioTech: A Prescription for Progression - Market Research on Biomoda, Inc. and Harbor BioSciences, Inc. [View article]
    HRBR, Harbor BioSciences;

    Filed SEC Form 25-NSE:10-2010;

    Pursuant to 17 CFR 240.12d2-2(b), NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12; [NasDaq];

    Per Equity; Development Stage Since Aug-1994; @ 19.3 Cents; Price Weighted over 104 DAYS; Volume 10.033,500M; Avg Daily Volume 96K; Market Cap per Time Frame Approx 2M;

    Report Category, ,Notes, Report, Price, , Metric, , Weight, , Primary Weight Adj Trading Metric, ,Year / Desig/ DAY Weight Adj Price.

    20. Deficit, (260) ,M, 10-Q 0.193 , (0.03) , 0.78 , (0.02) , 104 DAYS 2011, 0.15

    21. Paid In Equity, 263 ,M, 10-Q 0.193 , 0.03 , 0.98 , 0.03 , 104 DAYS 2011, 0.19

    22. Preferred, 0 ,M, 10-Q 0.193 , 0 , 1.04 , 0.0 , 104 DAYS 2011, 0.20

    23. Common Stk Amt, 0.35 ,M, 10-Q 0.193 , 19 , 1.14 , 22 , 104 DAYS 2011, 0.22

    24. Other Inc or Loss (0.35) ,M, 10-Q 0.193 , (20) , 1.19 , (24) , 104 DAYS 2011, 0.23

    Sum Trading At: ,Primary Metric per Equity: $3.472 M, (0.48_3) ,Metric Weighted per Price Range / Change, 5.12_95_404 ,Combined Weight Adj Trade Metric, (1.57_03_07) ,for -($0.2)M Market Cap, for, (0.005) off level price of .19_8;

    Estimate of Forward Activity:

    Equity $$MM, Development Stage Since Aug-94: 3.472
    MinRetGrowth: 0.03
    MinRetInv: 0.05
    Weighted Cost of Capital: 101.33%
    Estimated Local Continuing Value in $$M: 1.4
    Estimated Factor NOT LOCAL in $$M: (3.98)
    Estimated ContinuingValue :In Line With R&D Expense Annualized 2011: (5.65404)
    Est NOT LOCAL Price / 3.919M Market Cap : 0.1105
    (0.15_94_22_12) ,Factor Forward.
    (0.69_3) ,Not Local Price To.

    Quote Enter HRBR and Get Info @ :

    otcbb.com/asp/Info_Cen...

    Profile:

    finance.yahoo.com/q/pr...

    Formerly known as Hollis-Eden Pharmaceuticals;

    Website:
    www.harborbiosciences.com/

    2003:$35.00 on 5M Shares Trading; 2010 High _.75; Last traded Above 99 Cents; Late 2008;

    Do not own Shares of HRBR; Review Company;
    Jul 6, 2011. 09:35 AM | Likes Like |Link to Comment
  • Vicor Technologies (OTCBB: VCRT) - Breaking down the "PD2i(R) Studies" [View instapost]
    VCRT: Vicor Technologies:

    Current Market Cap; 7.06M;

    @ 10 Cents; Per Equity; Accum Deficit (59.708M); Equity (8.428M);
    Development Stage Since 2000;

    Desired Level / Sum Trading At: ,Primary Metric per Equity: ($8.428) M, 1000.013 ,Metric Weighted per Price Range / Change, 6.8_12_404 ,Combined Weight Adj Trade Metric, 1512.106 ,for -($1.7)M Market Cap, for, (0.04) off .14;

    Estimate of Forward Activity:

    Equity Deficit$$MM: (8)
    MinRetGrowth: 0.03
    MinRetInv: 0.05
    Weighted Cost of Capital: 85.904%
    Estimated Local Continuing Value in $$M: (4)
    Estimated Factor NOT LOCAL in $$M: 1.33
    Estimated ContinuingValue : In Line with Development Stage Expenses Since 2000;: (5.436,551)
    Est NOT LOCAL Price / 4.048M Market Cap : 0.08606
    (0.12) ,Factor Forward.
    (0.74) ,Not Local Price To.

    Profile:
    Vicor is a medical diagnostics company focused on commercializing noninvasive diagnostic technology products based on its patented, proprietary point correlation dimension algorithm (the PD2i® Algorithm”).
    The PD2i®Algorithm facilitates the ability of physicians to accurately risk stratify a specific target population to predict future pathological events such as autonomic nervous system dysfunction, cardiac mortality (either from arrhythmic death or congestive heart failure) and imminent death from trauma.
    The Company believes that the PD2i® Algorithm represents a noninvasive monitoring technology that physicians and other members of the medical community can use as a new and accurate vital sign and is currently commercializing two proprietary diagnostic medical products which employ software utilizing the PD2i® Algorithm: the PD2i Analyzertm (sometimes also referred to as the PD2i Cardiac Analyzertm and the PD2i-VStm (Vital Sign). It is also anticipated that the PD2i®Algorithm applications will allow for the early detection of cerebral disorders as well as other disorders and diseases.

    Quote:

    Enter VCRT and Get Info @

    otcbb.com/asp/Info_Cen...

    Off the high of 75 Cents;

    Do not own Shares of VCRT; Review the Company;
    Jul 5, 2011. 10:06 AM | Likes Like |Link to Comment
  • VPRO,Viropro,DSTI,Day Star Technologies,CTIC,Cell Therapeutics [View instapost]
    VIROPRO; VPRO;

    Announcing Name Change @ Next Meeting of Shareholders;

    Development Stage Since July-2003; however has not reported financials since May-10;

    Per Last Equity Reported (459,299K) and with the addition of the following criteria;

    Report a PROForma Fwd Net Loss of (1.763_656M); Per Next Report; [In line with Development Stage Expenses, Since ‘03]

    What would the company look like??? @ .06 or 6 Cents;;

    Report Category, ,Notes, Report, Price, , Metric, , Weight, , Primary Weight Adj Trading Metric, ,Year / Desig/ DAY Weight Adj Price.

    20. Deficit, (16.08) ,M, 10-Q 0.06 , (0.63) , 0.9 , (0.57548) , July 2011, 0.06

    21. Paid In Equity, 15.6 ,M, 10-Q 0.06 , 0.6472 , 0.8 , 0.5393 , July 2011, 0.05

    22. Preferred, 0 ,M, 10-Q 0.06 , 0 , 1.0 , 0 , July 2011, 0.06

    23. Common / Other, 0.0224 ,M, 10-Q 0.06 , 452 , 0.9 , 403 , July 2011, 0.05

    24. Report a Fwd Net Loss (1.763_656) ,M, 10-Q 0.06 , (5.724664) , 0.9 , (5.343) , July 2011, 0.06

    Sum Trading At: ,Primary Metric per Adjusted Equity: ($2.222,756) M, 445.86 ,Metric Weighted per Price Range / Change, 4.56 ,Combined Weight Adj Trade Metric, 397.404 ,for +$0.9M Market Cap, for, 0.005 on .055;


    Description of Company;
    Viropro Inc., a public company, offers Contractual Research and Manufacturing Services to the biopharmaceutical industry through cell line and process development.

    The Manufacturing Processes Developed Are Out-licensed to various international partners who produce and distribute the final product. The company is currently seeking partnerships for its biosimilar (aka follow-on biologics) cell lines and manufacturing processes.

    Viropro uses patented cell lines and expression vectors that clearly out-perform the industry standards and allow partnering companies to obtain industrially competitive yields. Our technology is ideally suited for Monoclonal Antibody process development.

    Viropro, Inc. conducts operations through its subsidiaries Viropro International Inc., Biologics Process Development, Inc. and Alpha Biologics Sdn. Bhd.
    Viropro specializes in the transfer of its technologies for industrial production of biopharmaceutical therapeutic proteins for the treatment of various diseases including cancer, diabetes, hepatitis and multiple sclerosis.
    The Company’s principal objective is to provide its high-yield manufacturing process technology to biopharmaceutical companies in global markets with unmet medical and/or market needs.

    Website:
    (viropro.com);

    BPD, located in Poway, CA, has been providing contract laboratory services to the biotechnology and biopharmaceutical industries for more than decade. The range of services includes molecular biology, cell culture, fermentation, protein purification, frozen storage, contract manufacturing, process scale-up and consulting services. BPD has an impressive list of clients that range from university laboratories to well-known biotechnology and biopharmaceutical companies.

    Website:
    (biologicspd.com)

    Intas Biopharmaceuticals Limited is a fully integrated biopharmaceutical company based out of Ahmedabad, Gujarat, India. Since launch of biotechnology operations in May 2000, Research & Development (R&D) and Manufacturing of Biopharmaceutical products with a special focus on Oncology (Cancer) are the major thrust areas for the company. Intas Biopharmaceuticals is India's first and only biopharmaceutical company to receive European Union -Good Manufacturing Practice (EU-GMP) certification for its manufacturing facility.

    Website:
    (intasbiopharma.co.in)


    Quote Enter VPRO and Get Info @

    otcbb.com/asp/Info_Cen...


    Profile:

    finance.yahoo.com/q/pr...

    2006: 1.50 / Share;
    Recently off the low of .0023, and the high of 14 Cents;

    [X] Own Shares and Review the Company;
    Jul 4, 2011. 09:22 AM | Likes Like |Link to Comment
  • 11 Advertising Stocks That You Might Be Tempted to Buy [View article]
    Update on ADST:ADSTAR, Inc;

    messages.finance.yahoo...

    See Post on Yahoo Finance Message Board;
    Jul 3, 2011. 06:00 PM | Likes Like |Link to Comment
  • American Medical Alert Corp. Q4 2007 Earnings Call Transcript [View article]
    MDHI; MEDICAL ALARM CONCEPTS.


    MDHI, Medical Alarm Concepts, is similar to AMAC, Mentioned Above;
    There was no specific mention of MDHI on seekingalpha.com; and this is an outdated posting; Adequate area to post information on MDHI.....
    Similar Companies;

    MDHI has some active interest in the company; There has been 3 Schedule 13D's filed recently; [General statement of acquisition of beneficial ownership];

    Also, Filed to Report 10-Q Late; Company may be in the process of being purchased..... Finalizing Equity Schedules; etc;

    Current Market Cap 475.3K; Last .0015 / Share;

    Per Most Recent Quarterly Report, Per Equity @ .001275_404 / Share; 316.863M Shares O/S; Market Cap of 404K;

    Sum Trading At: ,Primary Metric per Equity: ($2.049) M, 0.022504 ,Metric Weighted per Price Range / Change, 6.4_78_404 ,Combined Weight Adj Trade Metric, 0.03000375 ,for -($0.119_46)M Market Cap, for, (0.00038) off .00165;

    Estimate of Forward Activity:

    Equity Deficit$$MM: (2.049)
    MinRetGrowth: 0.03
    MinRetInv: 0.05
    Weighted Cost of Capital: 71.4%
    Estimated Local Continuing Value in $$M: (1.204_702)
    Estimated Factor NOT LOCAL in $$M: 1.000102
    Estimated ContinuingValue : In Line with 6 Mos Loss Annualized: (1.204_823)
    Est NOT LOCAL Price : 0.0098
    (0.004), ,Factor Forward.
    (2.58_16_6) ,Price To.

    Quote:Enter MDHI & Get Info @

    otcbb.com/asp/Info_Cen...

    Profile:
    Medical Alarm Concepts™ currently offers a unique, patented medical emergency alarm system that is different from other personal emergency response (PERS) systems on the market today.
    MDHI's MediPendant™ product provides several revolutionary and highly desirable features, including the ability to speak and listen to the operator directly through the pendant, an extended range of up to approximately 600+ feet from the base station enabling the user to move virtually anywhere in or around their home, and a call center staffed around the clock with all EMT-certified operators, who are guaranteed to stay on the line with the MediPendant™ user until the problem is resolved or help arrives. MediPendant's™ advanced technology also allows for three-way calling between the operator, the user and the dispatched first responders and/or a friend and family member.

    They have also recently acquired two US Patents;
    Both patents relate to existing and future technologies in the design and functionality of the medical alarm, a market that is growing at unprecedented rates. The re-issuance of these patents is a significant step toward ensuring the long-term success of the Company with regards to both its existing line of products as well as new products that are currently in design and/or development.

    Link to Profile:

    finance.yahoo.com/q/pr...

    Website:

    www.medicalalarmconcep.../

    2009-Early 2010 $2.58 / Share;

    July-10,_ .0098 after a Selloff from 25 Cents on 21M Share Volume;

    YTD Volume Approaching 100M Shares;

    Disclosure: [X] Own Shares; and Review the Company;
    May acquire additional Shares;
    Jul 1, 2011. 10:19 AM | Likes Like |Link to Comment
  • 8th Annual Taglich Brothers Small Cap Equity Conference [View article]
    SCOLR Pharma Inc (SCLR)

    $ 0.10, -0.01, (-9.09%)

    Per Equity of 2M @ .063;


    Sum Trading At:, Primary Metric per Equity: $2 M, 63, Metric Weighted per Price Range / Change, 7.475 ,Combined Weight Adj Trade Metric, 99.99_22_404 ,for -($1.5533)M Market Cap, for, (0.031) off .094;

    Estimate of Forward Activity:

    Accum Deficit$$MM: (75)
    MinRetGrowth: 0.03
    MinRetInv: 0.05
    Weighted Cost of Capital: 100%
    Estimated Local Continuing Value in $$M: (29.373)
    Estimated Factor NOT LOCAL in $$M: (0.027)
    Estimated ContinuingValue : Sales $$M / In Line w/ Recent Reports.: 0.8
    Est NOT LOCAL Price : 0.0675
    0.01599, ,Factor Forward.
    4.22_12_404, ,Not Local Price To.

    Quote:Enter SCLR and Get Info @

    otcbb.com/asp/Info_Cen...

    Profile:

    www.scolr.com/companyp...

    SCOLR’s first technology was licensed from Temple University in 1998 and since then has expanded to include three patented drug delivery technologies applicable to a wide variety of common and challenging classes of drugs and nutritional ingredients (U.S. patent Nos. 6,090,411; 6,337,091; 6,517,868; 6,936,275; 7,229,642; and Patents pending, and Patent Applications).

    SCOLR® Pharma is a specialty pharmaceutical company engaged in the development and licensing of its Controlled Delivery Technology (CDT®).
    The CDT platform consists of several patented oral drug delivery technologies for prescription, OTC and nutritional compounds.

    2006:$6.20 / Share.

    2008:$2.20 / Share.

    2010:_.75 / Share.

    June-2011:
    SCOLR Pharma, Inc. Announces Initial Closing of Private Placement.

    SCOLR Pharma, Inc. (OTC: SCLR) announced that it has closed the sale of $1 million principal amount of its 8% Debentures due 2013 (the "Debentures") in an initial closing of its private offering of up to $1.75 million principal amount of Debentures.
    The Company may offer additional Debentures, up to the aggregate maximum of $1.75 million, until June 30, 2011, unless extended.

    SCOLR Pharma, Inc. Presented at The Taglich Brothers 8th Annual Small Cap Equity Conference; before the announcement of the Private Equity Funding / Placement;

    Ceased trading on NYSE AMEX on 1-12-11;

    Do not own Shares of SCLR, Review the Company; Interested in the Company and the Sector;
    Jun 30, 2011. 04:49 AM | Likes Like |Link to Comment
  • RxNews Recap for Tuesday 12-22-09 [View instapost]
    CTD Holdings; CTDH;

    CTD Holdings, Inc. Manufacturing and marketing of Cyclodextrin-based compounds.

    per Equity @ .063 / Share;


    Sum Trading At: ,Primary Metric per Equity: $1.393 M, 630 ,Metric Weighted per Price Range / Change, 6.20 ,Combined Weight Adj Trade Metric, 903.622_404 ,for -($0.5)M Market Cap, for, (0.015) off .078

    Estimate of Forward Activity:

    Accum Deficit$$MM: (2.323)
    MinRetGrowth: 0.032
    MinRetInv: 0.059
    Weighted Cost of Capital: 158.813%
    Estimated Local Continuing Value in $$M: (0.7)
    Estimated Factor NOT LOCAL in $$M: 0.0174
    Estimated ContinuingValue : Operating Loss / In Line With Recent Reports: (0.0119)
    Est NOT LOCAL Price : 0.06
    (0.00033_4_13_8), ,Factor Forward.
    2.3346, ,Not Local Price To Sales. Avg Sales 910,233K, and Increasing;

    Quote:Enter CTDH and Get Info:

    otcbb.com/asp/Info_Cen...

    Profile:

    finance.yahoo.com/q/pr...

    Do not own Shares; Review the Company; Interested in Company and Sector;

    Current Market Cap:3.2M; Price to Sales 3.5x;

    2003:_.75 / Share;
    Jun 29, 2011. 09:06 AM | Likes Like |Link to Comment
  • Crop Production Services Expands Use of Converted Organics Organic Fertilizers on Blueberries & Wine Grapes in Oregon [View article]
    Paragraph 4 is an interesting note; Thanks for the post;.08 to .10 Recently, [+ or -]Apparently Delisting from Nasdaq; Starting Today.....That may change the pricing / trading;

    Per Equity of 6.2M @ .074

    Sum Trading At: ,Primary Metric per Equity: $6.2 M, 757 ,Metric Weighted per Price Range / Change, 5.20_86_74_3 ,Combined Weight Adj Trade Metric, 722.404_75 ,for -($0.3)M Market Cap, for, (0.003) off .0771;

    Forward:

    Accum Deficit$$MM: (102)
    MinRetGrowth: 0.03
    MinRetInv: 0.05
    Weighted Cost of Capital: 88.41%
    Estimated Local Continuing Value in $$M: (48)
    Estimated Factor NOT LOCAL in $$M: (0.067)
    Estimated ContinuingValue : Sales $$M: 3.204
    Est NOT LOCAL Price : 0.0675
    0.03, ,Factor Forward.
    2.33, ,Not Local Price To.

    '08:10.00, '10:_.75

    COIN & Get Info @
    otcbb.com/asp/Info_Cen...

    Profile:
    Converted Organics' (Nasdaq:COIN) mission is to promote, develop and operate profitable innovative clean technologies that contribute to the improvement of our environment by use of sustainable business practices and the judicious use of natural resources.
    Converted Organics Inc. is currently composed of three primary lines of business at the intersection of Agriculture, Water and Waste Recycling. Each business contributes to our mission and uses sustainable business practices that protect and value the environment. The three lines of business are Organic Fertilizer (Converted Organics), Vertical Farming (TerraSphere Systems - terraspheresystems.com), and Industrial Wastewater Treatment (Industrial Wastewater Resources).

    Do not own Shares; Review Company; Interested in the Company and Sector;
    Jun 29, 2011. 08:40 AM | Likes Like |Link to Comment
COMMENTS STATS
114 Comments
2 Likes